Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8190308.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a patient with multifocal motor neuropathy (MMN) who experienced a paradoxical decline in baseline strength to below pretreatment levels during a period of improvement associated with human immunoglobulin (HIG) administration. This outcome suggests that HIG may not limit progression of MMN and may reduce the utility of HIG as chronic therapy.
Medical subject headings
- Immunoglobulins, Intravenous
- Nervous System Diseases